- Report
- November 2022
- 154 Pages
Global
From €4826EUR$5,000USD£4,140GBP
- Report
- December 2022
- 425 Pages
Global
From €4766EUR$5,111USD£3,950GBP
- Report
- April 2022
Global
From €2896EUR$3,000USD£2,484GBP
- Report
- February 2023
- 240 Pages
Global
From €2896EUR$3,000USD£2,484GBP
- Report
- November 2021
- 222 Pages
Global
From €2896EUR$3,000USD£2,484GBP
- Report
- July 2021
- 60 Pages
Global
From €1930EUR$2,000USD£1,656GBP
- Drug Pipelines
- February 2018
- 440 Pages
Global
From €2316EUR$2,400USD£1,987GBP
- Report
- December 2018
- 288 Pages
Global
From €1327EUR$1,375USD£1,138GBP
€2654EUR$2,750USD£2,277GBP
- Report
- March 2023
- 157 Pages
Global
From €5309EUR$5,500USD£4,554GBP
- Report
- November 2021
- 255 Pages
Global
From €2654EUR$2,750USD£2,277GBP
€5309EUR$5,500USD£4,554GBP
- Report
- October 2022
- 100 Pages
Global
From €5743EUR$5,950USD£4,926GBP
- Report
- February 2023
- 30 Pages
Global
From €2654EUR$2,750USD£2,277GBP
- Report
- January 2022
- 200 Pages
Global
From €7239EUR$7,500USD£6,210GBP
- Report
- January 2022
- 60 Pages
Global
From €3813EUR$3,950USD£3,270GBP
- Report
- July 2022
- 100 Pages
Global
From €2654EUR$2,750USD£2,277GBP
- Report
- August 2018
- 15 Pages
Global
From €9652EUR$10,000USD£8,279GBP
- Report
- August 2018
- 17 Pages
Global
From €9652EUR$10,000USD£8,279GBP
- Report
- February 2022
- 44 Pages
Global
From €3378EUR$3,500USD£2,898GBP
- Drug Pipelines
- March 2021
Global
From €3378EUR$3,500USD£2,898GBP
- Drug Pipelines
- October 2020
- 56 Pages
Global
From €3378EUR$3,500USD£2,898GBP
The Oncogene market is a subset of the Genomics market that focuses on the study of cancer-causing genes. Oncogenes are genes that have the potential to cause cancer when they are mutated or expressed at high levels. Oncogenes are studied to understand the molecular basis of cancer and to develop new treatments. Research in this field has led to the development of targeted therapies, such as monoclonal antibodies, small molecule inhibitors, and gene therapies.
The Oncogene market is highly competitive, with many companies developing new technologies and treatments. Companies in the market include Illumina, Thermo Fisher Scientific, Qiagen, Agilent Technologies, and Bio-Rad Laboratories. Show Less Read more